Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone

Free Abstracts


  Free Subscription

Articles published in Lancet

Retrieve available abstracts of 35 articles:
HTML format
Text format

Single Articles

    November 2017
  1. WILLIAMS R, Alexander G, Armstrong I, Baker A, et al
    Disease burden and costs from excess alcohol consumption, obesity, and viral hepatitis: fourth report of the Lancet Standing Commission on Liver Disease in the UK.
    Lancet. 2017 Nov 28. pii: S0140-6736(17)32866.
    PubMed     Text format     Abstract available

    Eliminating viral hepatitis: time to match visions with action.
    Lancet. 2017;390:2121.
    PubMed     Text format    

  3. GARTNER C, Miller A, Bonevski B
    Extending survival for people with hepatitis C using tobacco dependence treatment.
    Lancet. 2017;390:2033.
    PubMed     Text format    

    September 2017
  4. GARCIA-TARDON N, Gresnigt TM, Fofanah AB, Grobusch MP, et al
    Hepatitis B and C in Tonkolili Province, Sierra Leone.
    Lancet. 2017;390:1485.
    PubMed     Text format    

    July 2017
  5. GREEN A
    The omitted epidemic-hepatitis E in the Lake Chad region.
    Lancet. 2017;390:443-444.
    PubMed     Text format    

    Growing concerns of hepatitis E in Europe.
    Lancet. 2017;390:334.
    PubMed     Text format    

  7. WIKTOR SZ, Scott JD
    What is the impact of treatment for hepatitis C virus infection?
    Lancet. 2017;390:107-109.
    PubMed     Text format    

  8. DOYLE JS, Thompson AJ, Higgs P, Stoove M, et al
    New hepatitis C antiviral treatments eliminate the virus.
    Lancet. 2017 Jul 6. pii: S0140-6736(17)31817.
    PubMed     Text format    

    February 2017
  9. EKSER B, Mangus RS
    Spontaneous bacterial peritonitis.
    Lancet. 2017;389:735.
    PubMed     Text format    

    January 2017
  10. VAN DER REE MH, de Vree JM, Stelma F, Willemse S, et al
    Safety, tolerability, and antiviral effect of RG-101 in patients with chronic hepatitis C: a phase 1B, double-blind, randomised controlled trial.
    Lancet. 2017 Jan 10. pii: S0140-6736(16)31715.
    PubMed     Text format     Abstract available

  11. ZEISEL MB, Baumert TF
    Clinical development of hepatitis C virus host-targeting agents.
    Lancet. 2017 Jan 10. pii: S0140-6736(17)30043.
    PubMed     Text format    

    December 2016
    Estimating the burden of hepatitis.
    Lancet. 2016;388:2738-2739.
    PubMed     Text format    

    November 2016
  13. GHINEA N, Lipworth W, Day R, Hill A, et al
    Importation of generic hepatitis C therapies: bridging the gap between price and access in high-income countries.
    Lancet. 2016 Nov 3. pii: S0140-6736(16)32051.
    PubMed     Text format    

    October 2016
  14. GAO YQ, Zhang X, Li M, Zhou ZH, et al
    Bushenjianpi formula combined with entecavir for HBeAg-negative chronic hepatitis B patients: a multicentre, randomised, double-blind, placebo-controlled trial.
    Lancet. 2016;388 Suppl 1:S33.
    PubMed     Text format     Abstract available

    September 2016
    Lasker Foundation announces award winners for 2016.
    Lancet. 2016;388:1144-5.
    PubMed     Text format    

  16. PIROTH L, Rabaud C, Rey D, Schmit JL, et al
    Hepatitis C: the path towards effective universal therapy.
    Lancet. 2016;388:1051-2.
    PubMed     Text format    

    July 2016

  17. Towards elimination of viral hepatitis by 2030.
    Lancet. 2016;388:308.
    PubMed     Text format    

  18. KAMARULZAMAN A, Reid SE, Schwitters A, Wiessing L, et al
    Prevention of transmission of HIV, hepatitis B virus, hepatitis C virus, and tuberculosis in prisoners.
    Lancet. 2016 Jul 14. pii: S0140-6736(16)30769.
    PubMed     Text format     Abstract available

  19. ALTICE FL, Azbel L, Stone J, Brooks-Pollock E, et al
    The perfect storm: incarceration and the high-risk environment perpetuating transmission of HIV, hepatitis C virus, and tuberculosis in Eastern Europe and Central Asia.
    Lancet. 2016 Jul 14. pii: S0140-6736(16)30856.
    PubMed     Text format     Abstract available

  20. DOLAN K, Wirtz AL, Moazen B, Ndeffo-Mbah M, et al
    Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees.
    Lancet. 2016 Jul 14. pii: S0140-6736(16)30466.
    PubMed     Text format     Abstract available

  21. RICH JD, Beckwith CG, Macmadu A, Marshall BD, et al
    Clinical care of incarcerated people with HIV, viral hepatitis, or tuberculosis.
    Lancet. 2016 Jul 14. pii: S0140-6736(16)30379.
    PubMed     Text format     Abstract available

  22. RUBENSTEIN LS, Amon JJ, McLemore M, Eba P, et al
    HIV, prisoners, and human rights.
    Lancet. 2016 Jul 14. pii: S0140-6736(16)30663.
    PubMed     Text format     Abstract available

  23. RATHI S
    Rules and rues.
    Lancet. 2016;388:122-3.
    PubMed     Text format    

  24. STANAWAY JD, Flaxman AD, Naghavi M, Fitzmaurice C, et al
    The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013.
    Lancet. 2016 Jul 6. pii: S0140-6736(16)30579.
    PubMed     Text format     Abstract available

  25. WIKTOR SZ, Hutin YJ
    The global burden of viral hepatitis: better estimates to guide hepatitis elimination efforts.
    Lancet. 2016 Jul 6. pii: S0140-6736(16)31018.
    PubMed     Text format    

    May 2016
  26. 'T HOEN EF
    Indian hepatitis C drug patent decision shakes public health community.
    Lancet. 2016 May 26. pii: S0140-6736(16)30656.
    PubMed     Text format    

  27. Hepatitis C: global ambition, national realities.
    Lancet. 2016;387:1970.
    PubMed     Text format    

  28. KELLY D
    Hepatitis C viraemia after apparent spontaneous clearance.
    Lancet. 2016;387:1968.
    PubMed     Text format    

  29. INDOLFI G, Mangone G, Bartolini E, Moriondo M, et al
    Hepatitis C viraemia after apparent spontaneous clearance in a vertically infected child.
    Lancet. 2016;387:1967-8.
    PubMed     Text format    

    April 2016
  30. LOCARNINI S, Chen DS, Shibuya K
    No more excuses: viral hepatitis can be eliminated.
    Lancet. 2016;387:1703-4.
    PubMed     Text format    

    March 2016
  31. CSETE J, Kamarulzaman A, Kazatchkine M, Altice F, et al
    Public health and international drug policy.
    Lancet. 2016 Mar 23. pii: S0140-6736(16)00619.
    PubMed     Text format    

  32. CORRIGAN M, Alrubaiy L, China L
    Hepatology training in the UK.
    Lancet. 2016;387:1055.
    PubMed     Text format    

    January 2016
  33. MCCALL C
    Australia commits funds to curb hepatitis C epidemic.
    Lancet. 2016;387:419.
    PubMed     Text format    

    November 2015
  34. WILLIAMS R, Ashton K, Aspinall R, Bellis MA, et al
    Implementation of the Lancet Standing Commission on Liver Disease in the UK.
    Lancet. 2015;386:2098-111.
    PubMed     Text format    

  35. Hepatitis C: cost of lost opportunities.
    Lancet. 2015;386:1917.
    PubMed     Text format    

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.